Cardiol Therapeutics Inc. (CRDL) vs Immuneering Corporation (IMRX)
A side-by-side comparison of Cardiol Therapeutics Inc. and Immuneering Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRDL
Cardiol Therapeutics Inc.
$1.32HealthcareDelayed quote: Oct 6, 2026, 10:09 AM EDT
IMRX
Immuneering Corporation
$3.99HealthcareDelayed quote: Oct 6, 2026, 10:10 AM EDT
Total return — CRDL vs IMRX
growth of $100 · dividends reinvested · last 5yCRDL -41.3% (-10.1%/yr)IMRX -77.0% (-25.5%/yr)CRDL compounded faster over this window
CRDL IMRX
CRDL vs IMRX: by the numbers
- •CRDL is the larger company ($152M vs $145M market cap).
Metrics side by side
Valuation
| Metric | CRDL | IMRX |
|---|---|---|
| P/B ratio | 8.96 | 0.76 |
Profitability
| Metric | CRDL | IMRX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -155.34% | -30.03% |
| ROIC | -165.56% | -32.73% |
Growth (annualized)
| Metric | CRDL | IMRX |
|---|---|---|
| Total return CAGR (5Y) | -18.36% | -32.77% |
Frequently asked
- How have CRDL and IMRX total returns compared?
- Over the past 5 years, CRDL delivered -18.36% and IMRX delivered -32.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.